Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Human Mutation|April 14, 2025
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation HotspotsGrégory Lazarian, Bernard Leroy, Floriane Theves, et al.
Cell Reports|January 23, 2020
Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone MarrowEtienne Paubelle, Florence Zylbersztejn, Thiago Trovati Maciel, et al.
Clinical Lung Cancer|July 2, 2020
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer PatientsElisa Gobbini, Anne Claire Toffart, Maurice Pérol, et al.
BMC Public Health|March 3, 2021
A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohortHervé Ghesquières, Cédric Rossi, Fanny Cherblanc, et al.
Clinical Nuclear Medicine|June 11, 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T CellsPierre Sesques, Jérémie Tordo, Emmanuelle Ferrant, et al.
Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.
The Lancet. Oncology|February 25, 2018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohortsSarah Huet, Bruno Tesson, Jean-Philippe Jais, et al.
The Journal of Clinical Investigation|May 27, 2021
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogrammingSylvain Carras, Dimitri Chartoire, Sylvain Mareschal, et al.
Histopathology|March 21, 2013
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroupsTeresa Marafioti, Christiane Copie-Bergman, Maria Calaminici, et al.
American Journal of Hematology|August 4, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European centerPierre Sesques, Emmanuelle Ferrant, Violaine Safar, et al.
Pageof 12